Candel Therapeutics, Inc.:预计2026年第一季度发布第二阶段非小细胞肺癌长期存活者数据,第二阶段将在2026年第二季度启动
Candel Therapeutics, Inc.:预计2026年第一季度发布第二阶段非小细胞肺癌长期存活者数据,第二阶段将在2026年第二季度启动
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.